2022 Nebraska Oncology Society SABCS Review: Updates in the Manageme…

Nebraska Oncology Society

T. Mamounas

2022 Nebraska Oncology Society SABCS Review: Neo(Adjuvant) Breast Ca…

Nebraska Oncology Society

L. Kennedy

Improving Outcomes for Patients With HR+ BC: From Metastatic to Earl…

Keck School of Medicine of USC

H. Rugo

I SPY 2.2: Responsive, Adaptive Trial to Prioritize Promising Invest…

Keck School of Medicine of USC

L. Esserman

SABCS 2021 Interim Analysis of the PREDICT Registry: Changes in Trea…

SABCS 2021 Conference Coverage on VuMedi

P. Whitworth

2022 Moffitt Cancer Center Updates in Breast Cancer Immunotherapy

Moffitt Cancer Center

H. Khong

2022 Nebraska Oncology Society SABCS Review: Updates in Radiation On…

Nebraska Oncology Society

W. Woodward

2022 Cleveland Clinic Updates on the Management of HR+ Breast Cancer

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Kruse

AACR 2022 Multiomic, Plasma-Only ctDNA Assay Identifies Breast Cance…

Wolfgang Janni

Tailoring Breast Cancer Radiation Therapy in the 21st Century

ecancer

P. Poortmans

The RxPONDER Trial and Its Impact on Best Clinical Practice in HR+/H…

ecancer

C. Markopoulos, G. Curigliano

Adjuvant Capecitabine for EBC: 15-Year OS Results of the FinXX Trial

Heikki Joensuu